Herceptin

Metastatic breast cancer Herceptin is indicated for the treatment of patients with metastatic breast cancer who have tumours that overexpress HER2: as monotherapy for the treatment of those patients who have received one or more chemotherapy regimens for their metastatic disease; or in combination

read more
technical specification